Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 2/20 | 0.62 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 10/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.54 |
| ▸ | POLB | P06746 | 7/20 | 0.54 |
| ▸ | DNMT1 | P26358 | 2/20 | 0.54 |
| ▸ | NSD2 | O96028 | 1/20 | 0.54 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.54 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | IDE | P14735 | 1/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.53 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.53 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16210975 | 1.00 | PDE4B (0.62) | PDE4BTAS2R14MEN1KMT2APOLB | |
| SCHEMBL16218029 | 1.00 | PDE4B (0.62) | PDE4BTAS2R14MEN1KMT2APOLB | |
| SCHEMBL12008808 | 0.85 | TAS2R14 (0.80) | TAS2R14MEN1KMT2APOLBDNMT1 | |
| SCHEMBL15761663 | 0.84 | MEN1 (0.59) | PDE4BMEN1KMT2APOLBDNMT1 | |
| SCHEMBL13726902 | 0.83 | PDE4B (0.58) | PDE4BMEN1KMT2APOLBDNMT1 | |
| SCHEMBL13726901 | 0.83 | PDE4B (0.58) | PDE4BMEN1KMT2APOLBDNMT1 | |
| SCHEMBL8187806 | 0.81 | PDE4B (0.61) | PDE4BTAS2R14MEN1KMT2APOLB | |
| SCHEMBL8187803 | 0.81 | PDE4B (0.61) | PDE4BTAS2R14MEN1KMT2APOLB | |
| SCHEMBL14414878 | 0.80 | MAPT (0.61) | PDE4BTAS2R14MEN1KMT2APOLB | |
| SCHEMBL8205510 | 0.78 | CTNNB1 (0.73) | PDE4BMEN1KMT2APOLBGFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140329674-A1 | Honeybee Repellents and Uses Thereof | INSCENT, INC. (US) | 2014-11-06 | — | — | US | claimed |
| WO-2014179785-A1 | IMPROVED HONEYBEE REPELLENTS AND USES THEREOF | INSCENT, INC. (US) | 2014-11-06 | — | — | WO | claimed |
| US-9796676-B2 | Honeybee repellents and uses thereof | INSCENT, INC. (US) | 2017-10-24 | — | — | US | disclosed |
| US-20160251312-A1 | Honeybee Repellents and Uses Thereof | INSCENT, INC. (US) | 2016-09-01 | — | — | US | disclosed |
| US-9357781-B2 | Honeybee repellents and uses thereof | INSCENT, INC. (US) | 2016-06-07 | — | — | US | disclosed |
| WO-2014179785-A1 | IMPROVED HONEYBEE REPELLENTS AND USES THEREOF | INSCENT, INC. (US) | 2014-11-06 | — | — | WO | disclosed |
| US-20140329674-A1 | Honeybee Repellents and Uses Thereof | INSCENT, INC. (US) | 2014-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160251312-A1 | Honeybee Repellents and Uses Thereof | ACHE, AHNAK, L3MBTL3 | PDE4B 2378/4885TAS2R14 367/4885MEN1 2382/4885 |
| US-20140329674-A1 | Honeybee Repellents and Uses Thereof | ACHE, AHNAK, L3MBTL3 | PDE4B 2378/4885TAS2R14 367/4885MEN1 2382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.